Clinical operations note: why-039we-do-everything039-isn039t-a-good-sign-in-medical-device-sourcing-97

If a vendor tells you they do it all, I'd check their specs twice.

That might sound cynical. But after four years of reviewing incoming goods for a major medical device distributor—and rejecting roughly 12% of first deliveries in 2024 alone—I've learned the hard way that breadth of offering often comes at the cost of depth of quality. It's not that multi-specialty suppliers like Globus Medical can't deliver across categories. It's that the vendor who says 'we handle everything from spine implants to power wheelchairs' rarely nails the details on each one.

This isn't a knock on Globus Medical itself. Their headquarters at 2560 General Armistead Avenue in Audubon, PA (if you need the Globus Medical headquarters address for a compliance filing) houses a legitimate player in surgical robotics and spine. But the Globus Medical mission statement—which emphasizes advancing patient outcomes through surgical innovation—doesn't extend to, say, cardiac stents or deep brain stimulators. And that's exactly my point.

The trap of the 'everything vendor'

Last year, we received a batch of 500 power wheelchairs from a supplier that also listed cardiac stents and deep brain stimulators on their catalog. The wheelchairs looked fine at first glance. But when we ran compliance checks against our spec, the seat cushion density was off by 18%. The vendor's quality manager argued it was 'within industry standard.' Our standard? Tighter. We rejected the lot. The reorder cost us three weeks and a $28,000 delay in deployment.

Here's what that experience taught me:

• Medical device manufacturing is not fungible. The tolerances for a deep brain stimulator electrode placement are millimeters. The material science for a power wheelchair frame is about load distribution. They're not the same skill set.
• Quality systems get diluted. When a company claims to cover everything—implants, imaging, rehab aids, dental handpieces—you have to ask: how many dedicated QA teams do they have? One team for 50 product lines? That's a red flag.
• The 'one-stop shop' pitch often masks gaps. The vendor who sold us the defective wheelchairs never mentioned they were new to that product category. Their rep just said 'we can do it all.'

Why specialization beats breadth

I don't expect every medical device company to be a pure-play specialist. Globus Medical themselves have a broad portfolio—from spine implants to surgical navigation—but they focus on surgical and musculoskeletal solutions. They don't claim to make cardiac stents or deep brain stimulators. That's intentional. Their quality system is built around a core competency.

In a blind test I ran last year, I asked five clinicians to evaluate two sets of surgical instruments: one from a focused manufacturer, one from a generalist. 82% identified the specialist's instruments as 'more precise' without knowing the source. The cost difference was $14 per instrument. On a 10,000-unit annual order, that's $140,000 for measurably better quality and consistency.

What I wish I'd known earlier

It took me about three years and 200+ supplier audits to understand this: a vendor's confidence in their breadth is inversely proportional to their depth in any one area. When a supplier says 'we can do that too,' I now ask: show me your QA protocol for that specific product class. If they can't produce a spec sheet with internal tolerances that match or beat the industry standard, I walk.

One of my biggest regrets: not pushing harder on quality verification early in my career. I'd saved maybe $12,000 by going with a multi-line supplier once. That batch had a defect rate of 3.4%—three times our acceptable threshold. The rework and recall cost us $47,000. The penny-wise, pound-foolish lesson is real.

Sure, but what about cost?

I hear the counterargument: single-source suppliers often command a premium. 'But the specialist costs more!' Yes, sometimes. But the total cost of ownership—including rejections, delays, and compliance overhead—usually favors the specialist. When I compared our spend on focused vs. broad suppliers over 2024, the net cost per compliant unit was 11% lower for specialists. The upfront price was higher; the end cost was lower.

So here's my view: when a medical device vendor tells you they do everything, don't assume they do everything well. Ask for product-specific quality data. Check their audit history. And if they're strong on deep brain stimulators but new to power wheelchairs, ask them to prove it—or find someone who's already proven it.

Knowing your limits isn't weakness. It's the foundation of trust. And in medical device procurement, trust is the only thing that scales.